---
schema_version: '1.0'
id: government-20260721-6c897b
content_kind: government-document
url: https://www.federalregister.gov/documents/2026/07/21/2026-14672/expedited-investigational-new-drug-pilot-program-request-for-information-extension-of-the-comment
url_hash: 6c897bb4af01a5ec77c47c148e5be128cd51ccbc4644639adbd28be3ed81564b
canonical_url: https://www.federalregister.gov/documents/2026/07/21/2026-14672/expedited-investigational-new-drug-pilot-program-request-for-information-extension-of-the-comment
source: us-federal-register
category: government/us
category_raw: Notice
country: us
region: us
tags: []
lang: en
published_at: '2026-07-21T00:00:00Z'
fetched_at: '2026-07-22T16:02:01.581489Z'
updated_at: '2026-07-22T16:14:35Z'
status: published
content_hash: e1646335f3ea71b19d89b11787519da40da9324966e705e30b6f8ed75d66ba6f
content_changed_at: null
license_note: full
license_basis: public-domain-17usc105
body_available: false
attribution: 'Source: Office of the Federal Register, National Archives and Records
  Administration'
license_rule: source:us-federal-register
summary: The Food and Drug Administration (FDA or the Agency) is extending the comment
  period for the notice that appeared in the Federal Register of June 24, 2026, to
  open a public docket to solicit input and comments on a proposal to establish a
  pilot program, the Expedited Investigational New Drug (IND) pilot program, to shorten
  the time it takes from drug identification to first-in-human (FIH) study, while
  protecting clinical trial participants.
summary_source: official
summary_en: The Food and Drug Administration (FDA or the Agency) is extending the
  comment period for the notice that appeared in the Federal Register of June 24,
  2026, to open a public docket to solicit input and comments on a proposal to establish
  a pilot program, the Expedited Investigational New Drug (IND) pilot program, to
  shorten the time it takes from drug identification to first-in-human (FIH) study,
  while protecting clinical trial participants.
provenance:
  doc_id: 2026-14672
  doc_id_scheme: fr_docnum
  issuer:
  - Health and Human Services Department
  - Food and Drug Administration
  doc_type: Notice
  subtype: null
  action: Notice; request for information; establishment of a public docket; extension
    of the comment period.
  significant: null
entities:
- name: New Policies
  type: UNKNOWN
- name: DrugSmuggling
  type: event
- name: GitHub Copilot
  type: artifact
- name: H-2A Visa Program Overhaul
  type: event
- name: observation request
  type: UNKNOWN
key_facts: []
related: []
related_auto:
- name: 精神保健サービス
  type: UNKNOWN
  weight: 1.0
- name: Cat
  type: creature
  weight: 1.0
- name: CorrectionalColonyNo_17
  type: location
  weight: 1.0
- name: agent_b_bot
  type: person
  weight: 1.0
- name: Agent_n8n_1_bot
  type: person
  weight: 1.0
title: Expedited Investigational New Drug Pilot Program; Request for Information;
  Extension of the Comment Period
---

# Expedited Investigational New Drug Pilot Program; Request for Information; Extension of the Comment Period

## TL;DR
The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice that appeared in the Federal Register of June 24, 2026, to open a public docket to solicit input and comments on a proposal to establish a pilot program, the Expedited Investigational New Drug (IND) pilot program, to shorten the time it takes from drug identification to first-in-human (FIH) study, while protecting clinical trial participants.

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [Expedited Investigational New Drug Pilot Program; Request for Information; Extension of the Comment Period](https://www.federalregister.gov/documents/2026/07/21/2026-14672/expedited-investigational-new-drug-pilot-program-request-for-information-extension-of-the-comment) — published 2026-07-21T00:00:00Z